Skip to main content

The PPA starts July 2025 and is expected to cover the total electricity consumption at the company’s Hillerød, Denmark biopharmaceutical manufacturing site, including new operations coming online in 2024. The financial terms of the agreement are not disclosed

Through the PPA, Fujifilm Diosynth Biotechnologies contributes to establishing a new solar park near Vedde with 107 MW in Sorø municipality, 80 kilometres from Hillerød. The solar park is expected to have an annual production capacity of 110 GWhIn addition to offsetting the energy consumption of the Hillerød biopharmaceutical manufacturing site, the solar park will increase the amount of renewable energy in the Danish power grid.

Local cooperation to include nature and recreational initiatives

Better Energy has worked closely with the local Sorø municipality and community members to develop a solar park that will include several nature and recreational initiatives, including 4 kilometres of trail systems and a pedestrian tunnel to connect the landscape to the village of Vedde.

“Fujifilm Diosynth Biotechnologies is committed to doing our part to address climate change and support Fujifilm’s SVP 2030 initiatives,” said Lars Petersen, president and CEO, Fujifilm Diosynth Biotechnologies. “This agreement completes an important aspect of our climate strategy, Partners for the Planet,” continued Petersen, “When the Vedde solar park and the Blevins (Texas) Solar Project previously announced by Fujifilm Holdings America Corporation come online, all our seven manufacturing sites globally will be sourcing electricity generated by renewable energy,” concluded Petersen. (hcn)